We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pencil Beam Radiation Offers More Targeted Therapy with Fewer Side Effects for Lung Cancer Patients

By MedImaging International staff writers
Posted on 16 Nov 2010
Pencil beam scanning technology, a targeted form of radiation treatment known as proton therapy, is now being used to treat patients with lung cancer.

Proton therapy's advantage over conventional forms of radiation from its ability to deliver radiation doses to a targeted tumor with remarkable precision that avoids surrounding tissue. This results in fewer side effects during and after treatment, and greater tumor control. Most proton therapy patients are treated with a technique known as passive scattering, which uses apertures to shape the proton beam and deliver a uniform dose to the tumor.

Pencil beam scanning proton therapy delivers a single, narrow proton beam (which may be less than a millimeter in diameter) that is magnetically swept across the tumor, depositing radiation similar to a painter's brush, without the need to construct beam-shaping devices. This technology continues to build on the patient benefits already offered with proton therapy more targeted, higher tumor dose, shorter treatment times, reduced side effects, and increased treatment options.

"The advantage lies in the beam's capacity to approach the tumor from multiple directions, creating a "U” shape around these structures and avoiding them entirely during treatment,” said James D. Cox, M.D., professor and head of the division of radiation oncology at MD Anderson Cancer Center (Houston, TX, USA). "Pencil beam is more like a very fine airbrush. Instead of needing a brass template to define the shape, the proton beam is made ultra fine to conform to the contours and landscapes of the tumor.”

MD Anderson's Proton Therapy Center, which began treating patients in May of 2006, is the first in North America and only one of three clinical centers in the world to treat patients with pencil beam scanning technology. Additionally, MD Anderson is the first center in the world to treat lung cancer patients using pencil beam scanning proton therapy.

"The unique part about lung cancer is that it's close to the esophagus, aorta, and spinal cord, and all of these critical structures are important for the body to function,” said Joe Chang, M.D., Ph.D., associate professor in MD Anderson's department of radiation Oncology. "The proton beam provides much more conformal radiation, which means higher doses to tumors and lower dosages to critical structures nearby.”

Another advantage of pencil beam scanning proton therapy is its use in patients with recurrent disease, who have already received full doses of radiation, according to Dr. Chang. In this instance, pencil beam limits or eliminates radiation to these sensitive areas. As the therapy advances, one of the next steps is using imaging tools to predict the movement of tumors, both lung and other cancers, to offer even greater precision.

Related Links:

MD Anderson Cancer Center


Digital Radiographic System
OMNERA 300M
Ultrasound Needle Guidance System
SonoSite L25
MRI System
nanoScan MRI 3T/7T
Breast Localization System
MAMMOREP LOOP

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.